La faible sensibilisation face à une maladie cardiaque grave mais traitable pourrait mettre la vie de nombreux Canadiens en danger
September 15, 2020 10:26 ET
|
Heart Valve Voice Canada
Les maladies valvulaires cardiaques sont courantes, graves mais traitables; elles sont souvent associées au vieillissement, mais seulement 3 % des Canadiens plus âgés en connaissent la forme la plus...
Moffitt Cancer Center Takes Whole-Patient Treatment to Heart
May 08, 2020 10:28 ET
|
Moffitt Cancer Center
Tampa, Fla., May 08, 2020 (GLOBE NEWSWIRE) -- Heart disease is the leading cause of death for men and women and people of most racial and ethnic groups in the U.S. According to the CDC, it is also...
Fitness Still Matters to Reduce Heart Disease and Cancer Deaths, Despite Advances in Modern Medicine and Lifestyle Changes
March 31, 2020 10:54 ET
|
Cooper Aerobics
DALLAS, March 31, 2020 (GLOBE NEWSWIRE) -- Over the last 50 years, advances in modern medicine have helped us live longer by identifying and treating risk factors for heart disease, stroke and...
Novartis announces NEJM publication of three pivotal trials showing durable and potent efficacy of inclisiran, an investigational first-in-class siRNA cholesterol-lowering therapy
March 18, 2020 17:01 ET
|
Novartis International AG
Inclisiran, an investigational medicine, showed durable and potent reduction of low-density lipoprotein cholesterol (LDL-C) in patients with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk...
Mazola Heart of Gold Campaign Raises Funds for Heart & Stroke
February 12, 2020 11:03 ET
|
Heart & Stroke Foundation
Toronto, Ontario, Feb. 12, 2020 (GLOBE NEWSWIRE) -- February is Heart Month. Heart disease and stroke are two of the three leading causes of death in Canada affecting more than 1.6 million Canadians...
FDA Grants ‘Breakthrough’ Designation to Eko’s ECG-based Low Ejection Fraction Screening Algorithm, Designed to Improve Detection of Heart Failure
December 18, 2019 09:00 ET
|
Eko
San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug...
AI-Powered Digital Health Company Eko Closes $20 Million Series B to Continue the Fight Against Heart Disease
September 25, 2019 09:02 ET
|
Eko
San Francisco, CA, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Eko, a Silicon Valley-based digital health company building machine learning tools to fight heart disease, today announced it has secured $20...
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Following Significant Scientific Achievement
September 16, 2019 08:00 ET
|
BIOLIFE4D
Company surpasses $3M in accepted investments CHICAGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for...
BIOLIFE4D Launches Second Regulation A+ (Mini-IPO) Offering Due to Popular Demand
September 06, 2019 07:30 ET
|
BIOLIFE4D
CHICAGO, Sept. 06, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched its...
American Kidney Fund to Host CDC Million Hearts Collaboration Biannual Meeting, Spotlighting Connection Between Kidney Disease and Heart Disease
March 26, 2019 13:53 ET
|
American Kidney Fund
ROCKVILLE, Md., March 26, 2019 (GLOBE NEWSWIRE) -- As Kidney Month draws to a close, the American Kidney Fund (AKF) is hosting the March 27 biannual meeting of the Million Hearts® Collaboration,...